ArticleEndocrinology2026
Genetic ablation of the adult Leydig cell lineage reveals stem Leydig cells and a peritubular regenerative niche in mice.
Article in Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Differentiated Leydig cells (LCs) produce testosterone and INSL3, 2 hormones essential for male sex differentiation and fertility. In mice, the developmental origin of adult Leydig cells (ALCs) and the presence of stem Leydig cells (SLCs) in adulthood remain unresolved. To investigate this, we used the Leydig cell-specific Insl3iCre line combined with Rosa26lox-STOP-lox-iDTR/lox-STOP-lox-TdTomato to genetically ablate the committed LC lineage in adult mice. These mice displayed a normal phenotype without diphtheria toxin (DT). Following DT administration, TdTomato-positive and CYP17A1-positive LCs were eliminated within 4 to 7 days, leading to marked reductions in testosterone levels and androgen-dependent organ weights. Activated Caspase 3 confirmed apoptosis of targeted Leydig cells during the acute ablation phase. This was accompanied by transient macrophage recruitment as shown by F4-80 immunofluorescence, consistent with their involvement in clearing apoptotic Leydig cells. Importantly, COUP-TFII-positive/αSMA-negative/CYP17A1-negative/TdTomato-negative cells persisted adjacent to peritubular and perivascular myoid cells, identifying a candidate Insl3-negative precursor population. Newly emerging TdTomato-positive cells subsequently appeared predominantly around seminiferous tubules and, to a lesser extent, blood vessels, marking the onset of Leydig cell regeneration. Testosterone levels progressively recovered as these cells acquired CYP17A1 expression and populated the interstitial compartment. By 65 days post-DT, the ALC population and endocrine function were fully restored. These findings provide strong functional evidence for adult SLCs capable of repopulating the LC lineage after complete ablation and identify the peritubular compartment as a major regenerative niche. This inducible LC-depletion mouse model provides a powerful tool to investigate SLC biology and the mechanisms governing LC differentiation and testicular endocrine homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.